Friday, May 16, 2008
05.12.2008 - One Hard Week
This week really kicked my butt. I had chemo on 05.09.2008 and was sick all weekend and had to stay home from work on 05.12.2008. I didn't feel that good on 05.13.2008 or 05.14.2008, but was able to work.  On 05.15.2008, I had a doctor visit and my white blood cell count was low. That was to be expected due to the chemotherapy and they gave me a shot of Neulasta to boost my WBC count. I felt really tired that day and my boss told me before I left for the appointment to perhaps take a nap before returning to work. When I got home, I slept for about five hours and then had a normal evening and then slept my usual eight hours.  05.16.2008, I finally felt mostly normal. Still not perfect, but close. This may have been the hardest hit I have ever been from the chemo. Not fun.    
Saturday, May 10, 2008
05.09.2008 - One Day Chemo Session
On 05.09.2008, I had another chemotherapy session, but it was a one day session.  I couldn't drive myself, so my wife dropped me off and after they gave me a large dose of benadryl through the IV, I was out for hours.  I woke up and tried to do some work, but couldn't get anything done, so I gave it up.  Right as the nurse was disconnecting the IV, my brother-in-law arrived and picked me up and drove me home.  Timing worked out well, but I felt poorly the remainder of the evening.  I didn't feel great Saturday either.  The morning wasn't too bad, but it got unpleasant in the afternoon, and now I am perking up a bit.  I had to prepare two cases for trial for Monday and those are done.  I had a jury trial on Thursday and that was a good experience since I haven't had a jury trial since I went out for this medical situation in October of last year.  There wasn't a verdict.  The jury was deadlocked.  After multiple proclamations by the jury that they were unable to reach a unanimous verdict and two and a half hours of deliberating, the judge declared a mistrial.  The drugs in this IV session were Irinotecan (also known as Camptosar) and Taxol.
Subscribe to:
Comments (Atom)